Lv42
711 积分 2021-01-05 加入
Visible-Light-Promoted Copper-Catalyzed Etherification of Aryl Bromides via Energy Transfer
3小时前
已完结
Rational Design of a Potent, Selective, and Metabolically Stable CDK9 Inhibitor to Counteract Osimertinib Resistance through Mcl-1 Suppression and Enhanced BRD4 Co-Targeting
5小时前
已完结
Strengths, Weaknesses, Opportunities, and Potential Threat Analysis of Targeting Leucine-Rich Repeat Kinase 2 for Parkinson’s Disease Treatment: Status Quo and Quo Vadis
1天前
已完结
Discovery of Novel MTA-Cooperative PRMT5 Inhibitors with a 2,3-Dihydro-1H-imidazo[1,2-b]pyrazole Scaffold
2天前
已完结
Discovery of Novel c-MET Inhibitors for Hepatocellular Carcinoma Using an Integrated Virtual Screening Approach
2天前
已完结
Rational Design and Development of Novel CDK9 Inhibitors for the Treatment of Acute Myeloid Leukemia
4天前
已完结
Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy
4天前
已完结
Discovery of 1H-Pyrrolo[2,3-b]pyridine Derivatives as Highly Selective, and Orally Available ATM Inhibitors with Potent In Vivo Antitumor Activity
4天前
已完结
MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment
4天前
已完结
Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor
4天前
已完结
皖公网安备34019202002308
